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Background
Experimental evidence shows that the anti-nociceptive
action of endocannabinoids, related to the modulation of
the trigeminovascular system activity, may be helpful for
prompting new targets for the treatment of migraine.
URB602 is an inhibitor of monoacylglycerol lipase
(MAGL), a key enzyme in the hydrolysis of the endocan-
nabinoid 2-arachidonoylglycerol (2-AG). URB602 induces
analgesia in animal pain models not related to migraine,
but there is no pre-clinical information as regards to its
potential effect in migraine pain.
Aim
To evaluate whether URB602 administration interferes
with the level of activation of brain structures involved in
migraine.
Methods
Nitroglycerin (NTG) induces neuronal activation in a
specific subset of brain nuclei that are considered rele-
vant for the development of migraine attacks. In this
study we evaluated the changes caused by URB602 in
NTG-induced neuronal activation. Male Sprague Daw-
ley rats were treated with NTG (10mg/kg, i.p.) fol-
lowed by URB602 (2mg/kg, i.p.) or vehicle (DMSO,
1ml/kg, i.p.). Their brains were processed for the
detection of c-Fos protein, used as an indicator of
brain activation.
Results
URB602 alone did not change Fos expression in the
brain nuclei under evaluation. When administered
3 hours after NTG, URB602 reduced NTG-induced Fos
expression in all the cerebral areas that were examined,
with a significant effect in nucleus trigeminalis caudalis
and ventrolateral column of periaqueductal grey.
Conclusions
The inhibition of MAGL activity, with the theoretical
increase of central content of 2-AG, may modulate the
activation of structures involved in pain perception and
pain integration in an animal model specific for migraine.
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